Key points are not available for this paper at this time.
Abstract Background: In breast cancer diagnostics, the accurate assessment of HER2 status is essential for treatment stratification. Conventionally, HER2 immunohistochemistry (IHC) scoring necessitates specialized staining protocols, which are resource- and time-intensive. This study presents a virtual IHC (vIHC) digital assay to predict HER2 scores directly from hematoxylin and eosin (H Part 1 (Regular Abstracts) ; 2024 Apr 5-10; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2024;84 (6Suppl): Abstract nr 7391.
Building similarity graph...
Analyzing shared references across papers
Loading...
Misagh Naderi
Nikola Mitic
Nikola Spasic
Cancer Research
Hologic (United States)
Building similarity graph...
Analyzing shared references across papers
Loading...
Naderi et al. (Fri,) studied this question.
www.synapsesocial.com/papers/68e72e1db6db6435876a72eb — DOI: https://doi.org/10.1158/1538-7445.am2024-7391